Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4080
Source ID: NCT00939939
Associated Drug: Sitagliptin
Title: Effect of Sitagliptin on Postprandial Lipoprotein Metabolism
Acronym:
Status: TERMINATED
Study Results: NO
Results:
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG: sitagliptin|DRUG: glimepiride
Outcome Measures: Primary: incremental area under the triglyceride curve (iAUC-TG), incremental area under the plasma triglyceride concentration curve following a standardized oral fat challenge, 10 weeks | Secondary: LDL-cholesterol, fasting LDL-cholesterol, 10 weeks|HDL-cholesterol, fasting HDL-cholesterol, 10 weeks|VLDL-cholesterol, fasting VLDL-cholesterol, 10 weeks|triglycerides, fasting triglycerides, 10 weeks|area under the triglyceride curve (AUC-TG), area under the plasma triglyceride concentration curve following a standardized oral fat challenge, 10 weeks|area under the VLDL-triglyceride curve (AUC-VLDL-TG), area under the plasma VLDL-triglyceride concentration curve following a standardized oral fat challenge, 10 weeks|incremental area under the VLDL-triglyceride curve (iAUC-VLDL-TG), incremental area under the plasma VLDL-triglyceride concentration curve following a standardized oral fat challenge, 10 weeks|glucose, fasting glucose concentration, 10 weeks|insulin, fasting insulin concentration, 10 weeks|HOMA, 10 weeks|HbA1c, 10 weeks|interleukin-6, 10 weeks|hs-CRP, 10 weeks
Sponsor/Collaborators: Sponsor: Ludwig-Maximilians - University of Munich
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 3
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2010-03
Completion Date: 2011-05
Results First Posted:
Last Update Posted: 2011-06-27
Locations: Medical Dept. 2, Grosshadern, University Munich, Munich, 81377, Germany
URL: https://clinicaltrials.gov/show/NCT00939939